{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:14:23Z","timestamp":1764785663607,"version":"3.44.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013945","name":"Institut de Recherches Servier","doi-asserted-by":"publisher","award":["ANR MNPS 2009","ANR MNPS 2009"],"award-info":[{"award-number":["ANR MNPS 2009","ANR MNPS 2009"]}],"id":[{"id":"10.13039\/501100013945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR MNPS 2009","ANR MNPS 2009"],"award-info":[{"award-number":["ANR MNPS 2009","ANR MNPS 2009"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>In humans, vasopressin AVP1BR receptor (hV<jats:sub>1B<\/jats:sub>) plays key roles in hypothalamic\u2013pituitary\u2013adrenal (HPA) axis regulation and social behavior. Three hV<jats:sub>1B<\/jats:sub> polymorphisms, rs35369693 (K65N), rs28632197 (R364H) and rs33990840 (G191R), have been related to psychiatric disorders with altered HPA axis function and social behavior. The aim of this study was to explore hV<jats:sub>1B<\/jats:sub> pharmacological properties as a function of the polymorphism in transfected cells and the brain functioning in an emotional task in volunteers harboring different AVP1BR polymorphisms. Transfection rate, fluorescent imaging and inositol phosphate (IPs) accumulation were evaluated in HEK293 cells that expressed different hV<jats:sub>1B<\/jats:sub> variants: K65\/G191\/R364 (wild type), G191R, K65N and\/or R364H. Brain functional activity was investigated in 35 healthy men with different hV<jats:sub>1B<\/jats:sub> variants during an fMRI implicit emotional recognition paradigm. IPs accumulation after arginine vasopressin stimulation was much reduced in cells expressing hV<jats:sub>1B<\/jats:sub> K65N and\/or R364H, and increased in cells expressing G191R. Basal IPs accumulation, transfection rate, and fluorescent binding to plasma membrane were similar for all polymorphisms. During the anger vs. neutral face visualization task, activation of motor areas, visual areas, frontal sub-gyral area, hippocampus, and putamen was higher in homozygotes for the K65\/R364 haplotype than in heterozygotes. Analyses did not include participants with the G191 polymorphism because of its low frequency. Different hV<jats:sub>1B<\/jats:sub> polymorphisms could be candidates as biomarkers of psychiatric disorders. Moreover, hV<jats:sub>1B<\/jats:sub> may be a pharmacological target if these polymorphisms are considered.<\/jats:p>","DOI":"10.1186\/s12868-025-00963-7","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T18:22:00Z","timestamp":1752776520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A pharmacological and brain imaging study of human vasopressin AVP1BR receptor functional polymorphisms"],"prefix":"10.1186","volume":"26","author":[{"given":"Adri\u00e1n","family":"Alacreu-Crespo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Oli\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Mani\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Deverdun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Lebars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maith\u00e9","family":"Corbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Guillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Courtet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"963_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4615-4871-3_1","volume":"449","author":"S Jard","year":"1998","unstructured":"Jard S. Vasopressin receptors. A historical survey. Adv Exp Med Biol. 1998;449:1\u201313.","journal-title":"Adv Exp Med Biol"},{"key":"963_CR2","doi-asserted-by":"crossref","unstructured":"Caldwell HK. Oxytocin and vasopressin: powerful regulators of social behavior. Neuroscientist. 2017.","DOI":"10.1177\/1073858417708284"},{"key":"963_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1196\/annals.1296.018","volume":"1018","author":"GB Makara","year":"2004","unstructured":"Makara GB, Mergl Z, Zelena D. The role of vasopressin in hypothalamo-pituitary-adrenal axis activation during stress: an assessment of the evidence. Ann N Y Acad Sci. 2004;1018:151\u201361.","journal-title":"Ann N Y Acad Sci"},{"key":"963_CR4","doi-asserted-by":"publisher","unstructured":"Rivier C, Brownstein M, Spiess J, Rivier J, Valef W. In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, \u03b2-Endorphin, and corticosterone. Endocrinology. 1982. https:\/\/doi.org\/10.1210\/endo-110-1-272","DOI":"10.1210\/endo-110-1-272"},{"key":"963_CR5","doi-asserted-by":"crossref","unstructured":"Birnbaumer M. Vasopressin receptors. Trends in endocrinology and metabolism. 2000.","DOI":"10.1016\/S1043-2760(00)00304-0"},{"key":"963_CR6","doi-asserted-by":"crossref","unstructured":"Jard S, Gaillard RC, Guillon G, Marie J, Schoenenberg P, Muller AF et al. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol Pharmacol. 1986.","DOI":"10.1016\/S0026-895X(25)10336-2"},{"key":"963_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(84)90080-9","author":"FA Antoni","year":"1984","unstructured":"Antoni FA, Holmes MC, Makara GB, K\u00e1rteszi M, L\u00e1szl\u00f3 FA. Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary Corticotropin (ACTH) release are mediated by a novel type of receptor. Peptides (NY). 1984. https:\/\/doi.org\/10.1016\/0196-9781(84)90080-9.","journal-title":"Peptides (NY)"},{"key":"963_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-9084(85)80115-2","author":"CJ Kirk","year":"1985","unstructured":"Kirk CJ, Guillon G, Balestre MN, Creba JA, Michell RH, Jard S. Hormone-mediated inositol lipid breakdown in hepatocytes and WRK1 cells: relationship to receptor function. Biochimie. 1985. https:\/\/doi.org\/10.1016\/S0300-9084(85)80115-2.","journal-title":"Biochimie"},{"key":"963_CR9","doi-asserted-by":"crossref","unstructured":"M\u00fcller MB, Wurst W. Getting closer to affective disorders: the role of CRH receptor systems. Trends Mol Med. 2004.","DOI":"10.1016\/j.molmed.2004.06.007"},{"key":"963_CR10","doi-asserted-by":"crossref","unstructured":"Caldwell HK, Aulino EA, Rodriguez KM, Witchey SK, Yaw AM. Social context, stress, neuropsychiatric disorders, and the vasopressin 1b receptor. Front NeuroSci. 2017.","DOI":"10.3389\/fnins.2017.00567"},{"key":"963_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2012.07.031","author":"CC Zai","year":"2012","unstructured":"Zai CC, Muir KE, Nowrouzi B, Shaikh SA, Choi E, Berall L, et al. Possible genetic association between vasopressin receptor 1B and child aggression. Psychiatry Res. 2012. https:\/\/doi.org\/10.1016\/j.psychres.2012.07.031.","journal-title":"Psychiatry Res"},{"key":"963_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.10.1189","author":"EL Dempster","year":"2007","unstructured":"Dempster EL, Burcescu I, Wigg K, Kiss E, Baji I, Gadoros J, et al. Evidence of an association between the vasopressin V1b receptor gene (AVPR1B) and childhood-onset mood disorders. Arch Gen Psychiatry. 2007. https:\/\/doi.org\/10.1001\/archpsyc.64.10.1189.","journal-title":"Arch Gen Psychiatry"},{"key":"963_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.30750","author":"ME Keck","year":"2008","unstructured":"Keck ME, Kern N, Erhardt A, Unschuld PG, Ising M, Salyakina D, et al. Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case\/control study for panic disorder. Am J Med Genet Part B: Neuropsychiatric Genet. 2008. https:\/\/doi.org\/10.1002\/ajmg.b.30750.","journal-title":"Am J Med Genet Part B: Neuropsychiatric Genet"},{"key":"963_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.49","author":"YJ Ben-Efraim","year":"2013","unstructured":"Ben-Efraim YJ, Wasserman D, Wasserman J, Sokolowski M. Family-based study of AVPR1B association and interaction with stressful life events on depression and anxiety in suicide attempts. Neuropsychopharmacology. 2013. https:\/\/doi.org\/10.1038\/npp.2013.49.","journal-title":"Neuropsychopharmacology"},{"key":"963_CR15","doi-asserted-by":"crossref","unstructured":"Ebstein RP, Israel S, Lerer E, Uzefovsky F, Shalev I, Gritsenko I, et al. Arginine vasopressin and oxytocin modulate human social behavior. In: Annals of the New York Academy of Sciences; 2009.","DOI":"10.1111\/j.1749-6632.2009.04541.x"},{"key":"963_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/nn1463","author":"L Pezawas","year":"2005","unstructured":"Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci. 2005. https:\/\/doi.org\/10.1038\/nn1463.","journal-title":"Nat Neurosci"},{"key":"963_CR17","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4899-09.2010","author":"CF Zink","year":"2010","unstructured":"Zink CF, Stein JL, Kempf L, Hakimi S, Meyer-Lindenberg A. Vasopressin modulates medial prefrontal cortex-amygdala circuitry during emotion processing in humans. J Neurosci. 2010. https:\/\/doi.org\/10.1523\/JNEUROSCI.4899-09.2010.","journal-title":"J Neurosci"},{"key":"963_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(02)00133-6","author":"R Thompson","year":"2004","unstructured":"Thompson R, Gupta S, Miller K, Mills S, Orr S. The effects of vasopressin on human facial responses related to social communication. Psychoneuroendocrinology. 2004. https:\/\/doi.org\/10.1016\/S0306-4530(02)00133-6.","journal-title":"Psychoneuroendocrinology"},{"key":"963_CR19","doi-asserted-by":"crossref","unstructured":"Zink CF, Meyer-Lindenberg A. Human neuroimaging of oxytocin and vasopressin in social cognition. Horm Behav. 2012.","DOI":"10.1016\/j.yhbeh.2012.01.016"},{"key":"963_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2011.07.013","author":"JK Rilling","year":"2012","unstructured":"Rilling JK, DeMarco AC, Hackett PD, Thompson R, Ditzen B, Patel R, et al. Effects of intranasal Oxytocin and vasopressin on cooperative behavior and associated brain activity in men. Psychoneuroendocrinology. 2012. https:\/\/doi.org\/10.1016\/j.psyneuen.2011.07.013.","journal-title":"Psychoneuroendocrinology"},{"key":"963_CR21","doi-asserted-by":"publisher","DOI":"10.1210\/me.2011-1202","author":"B Murat","year":"2012","unstructured":"Murat B, Devost D, Andr\u00e9s M, Mion J, Boulay V, Corbani M, et al. V1b and CRHR1 receptor heterodimerization mediates synergistic biological actions of vasopressin and CRH. Mol Endocrinol. 2012. https:\/\/doi.org\/10.1210\/me.2011-1202.","journal-title":"Mol Endocrinol"},{"key":"963_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0378-1119(99)00468-0","volume":"241","author":"P Ren\u00e9","year":"2000","unstructured":"Ren\u00e9 P, Lenne F, Ventura MA, Bertagna X, de Keyzer Y. Nucleotide sequence and structural organization of the human vasopressin pituitary receptor (V3) gene. Gene. 2000;241:57\u201361.","journal-title":"Gene"},{"key":"963_CR23","doi-asserted-by":"publisher","DOI":"10.1021\/jm1016208","author":"M Corbani","year":"2011","unstructured":"Corbani M, Trueba M, Stoev S, Murat B, Mion J, Boulay V, et al. Design, synthesis, and Pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or Oxytocin receptors. J Med Chem. 2011. https:\/\/doi.org\/10.1021\/jm1016208.","journal-title":"J Med Chem"},{"key":"963_CR24","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-0062","author":"M Corbani","year":"2004","unstructured":"Corbani M, Gonindard C, Meunier JC. Ligand-regulated internalization of the opioid receptor-like 1: a confocal study. Endocrinology. 2004. https:\/\/doi.org\/10.1210\/en.2004-0062.","journal-title":"Endocrinology"},{"key":"963_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.pscychresns.2015.09.020","volume":"234","author":"E Oli\u00e9","year":"2015","unstructured":"Oli\u00e9 E, Ding Y, Le Bars E, de Champfleur NM, Mura T, Bonaf\u00e9 A, et al. Processing of decision-making and social threat in patients with history of suicidal attempt: a neuroimaging replication study. Psychiatry Res Neuroimaging. 2015;234:369\u201377.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"963_CR26","doi-asserted-by":"crossref","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960.","DOI":"10.1037\/t04100-000"},{"key":"963_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/mpr.54","volume":"8","author":"A Mackinnon","year":"1999","unstructured":"Mackinnon A, Ritchie K, Mulligan R. The measurement properties of a French Language adaptation of the national adult reading test. Int J Methods Psychiatr Res. 1999;8:27\u201338.","journal-title":"Int J Methods Psychiatr Res"},{"key":"963_CR28","doi-asserted-by":"crossref","unstructured":"Spielberger C. Manual for the State-Trait anxiety inventory (STAI). Consulting Psychologists Press. 1983;:4\u201326.","DOI":"10.1037\/t06496-000"},{"key":"963_CR29","doi-asserted-by":"publisher","DOI":"10.1207\/s15327752jpa6903_5","author":"DG Forgays","year":"1997","unstructured":"Forgays DG, Forgays DK, Spielberger CD. Factor structure of the state-trait anger expression inventory. J Pers Assess. 1997. https:\/\/doi.org\/10.1207\/s15327752jpa6903_5.","journal-title":"J Pers Assess"},{"key":"963_CR30","unstructured":"Manni\u00e9re M. Etude des propri\u00e9t\u00e9s fonctionnelles de variants de polymorphisme du r\u00e9cepteur V1B de La vasopressine d\u00e9tect\u00e9s Dans les troubles affectifs. University of Montpellier; 2015."},{"key":"963_CR31","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2010.09091379","author":"T Insel","year":"2010","unstructured":"Insel T, Cuthbert BN, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research domain criteria (RDoC): toward a new classification Framewotk for research of mental disorders. Am J Psychiatry. 2010. https:\/\/doi.org\/10.1176\/appi.ajp.2010.09091379.","journal-title":"Am J Psychiatry"},{"key":"963_CR32","first-page":"1659","volume":"142","author":"F Hernando","year":"2001","unstructured":"Hernando F, Schoots O, Lolait SJ, Burbach JPH. Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin. Undefined. 2001;142:1659\u201368.","journal-title":"Undefined"},{"key":"963_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0167-0115(87)90001-2","volume":"18","author":"G Guillon","year":"1987","unstructured":"Guillon G, Gaillard RC, Kehrer P, Schoenenberg P, Muller AF, Jard S. Vasopressin and angiotensin induce inositol lipid breakdown in rat adenohypophysial cells in primary culture. Regul Pept. 1987;18:119\u201329.","journal-title":"Regul Pept"},{"key":"963_CR34","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2826.2012.02303.x","volume":"24","author":"M Manning","year":"2012","unstructured":"Manning M, Misicka A, Olma A, Bankowski K, Stoev S, Chini B, et al. Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics. J Neuroendocrinol. 2012;24:609\u201328.","journal-title":"J Neuroendocrinol"},{"key":"963_CR35","doi-asserted-by":"publisher","first-page":"e49708","DOI":"10.1371\/journal.pone.0049708","volume":"7","author":"M Chafai","year":"2012","unstructured":"Chafai M, Corbani M, Guillon G, Desarm\u00e9nien MG. Vasopressin inhibits LTP in the CA2 mouse hippocampal area. PLoS ONE. 2012;7:e49708.","journal-title":"PLoS ONE"},{"key":"963_CR36","first-page":"7735","volume":"564","author":"F Leroy","year":"2018","unstructured":"Leroy F, Park J, Asok A, Brann DH, Meira T, Boyle LM, et al. A circuit from hippocampal CA2 to lateral septum disinhibits social aggression. Nat 2018. 2018;564:7735.","journal-title":"Nat 2018"},{"key":"963_CR37","doi-asserted-by":"crossref","unstructured":"Grill-Spector K, Weiner KS, Gomez J, Stigliani A, Natu VS. The functional neuroanatomy of face perception: from brain measurements to deep neural networks. Interface Focus. 2018;8.","DOI":"10.1098\/rsfs.2018.0013"},{"key":"963_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0006-8993(80)90435-7","volume":"197","author":"J Hawthorn","year":"1980","unstructured":"Hawthorn J, Ang VTY, Jenkins JS. Localization of vasopressin in the rat brain. Brain Res. 1980;197:75\u201381.","journal-title":"Brain Res"},{"key":"963_CR39","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuroscience.2006.08.040","volume":"143","author":"WS Young","year":"2006","unstructured":"Young WS, Li J, Wersinger SR, Palkovits M. The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy. Neuroscience. 2006;143:1031\u20139.","journal-title":"Neuroscience"},{"key":"963_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ygcen.2017.10.011","volume":"258","author":"M Corbani","year":"2018","unstructured":"Corbani M, Marir R, Trueba M, Chafai M, Vincent A, Borie AM, et al. Neuroanatomical distribution and function of the vasopressin V1B receptor in the rat brain Deciphered using specific fluorescent ligands. Gen Comp Endocrinol. 2018;258:15\u201332.","journal-title":"Gen Comp Endocrinol"},{"key":"963_CR41","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1017\/S0033291712002905","volume":"43","author":"Q Wang","year":"2013","unstructured":"Wang Q, Cheung C, Deng W, Li M, Huang C, Ma X, et al. Fronto-parietal white matter microstructural deficits are linked to performance IQ in a first-episode schizophrenia Han Chinese sample. Psychol Med. 2013;43:2047\u201356.","journal-title":"Psychol Med"},{"key":"963_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3109\/00952990.2014.985829","volume":"41","author":"SC Wollman","year":"2015","unstructured":"Wollman SC, Alhassoon OM, Stern MJ, Hall MG, Rompogren J, Kimmel CL, et al. White matter abnormalities in long-term heroin users: a preliminary neuroimaging meta-analysis. Am J Drug Alcohol Abuse. 2015;41:133\u20138.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"963_CR43","doi-asserted-by":"crossref","unstructured":"Sadeghi S, Takeuchi H, Shalani B, Taki Y, Nouchi R, Yokoyama R et al. Brain structures and activity during a working memory task associated with internet addiction tendency in young adults: a large sample study. PLoS ONE. 2021;16.","DOI":"10.21203\/rs.3.rs-153035\/v1"},{"key":"963_CR44","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s11682-013-9285-5","volume":"8","author":"D Neumann","year":"2014","unstructured":"Neumann D, Keiski MA, McDonald BC, Wang Y. Neuroimaging and facial affect processing: implications for traumatic brain injury. Brain Imaging Behav. 2014;8:460\u201373.","journal-title":"Brain Imaging Behav"},{"key":"963_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpsychires.2021.08.024","volume":"143","author":"M Kennedy","year":"2021","unstructured":"Kennedy M, Simcock G, Jamieson D, Hermens DF, Lagopoulos J, Shan Z. Elucidating the neural correlates of emotion recognition in children with sub-clinical anxiety. J Psychiatr Res. 2021;143:75\u201383.","journal-title":"J Psychiatr Res"},{"key":"963_CR46","doi-asserted-by":"crossref","unstructured":"Zeki S, Romaya JP. Neural correlates of hate. PLoS ONE. 2008;3.","DOI":"10.1371\/journal.pone.0003556"},{"key":"963_CR47","doi-asserted-by":"crossref","unstructured":"Crane NA, Chang F, Kinney KL, Klumpp H. Individual differences in striatal and amygdala response to emotional faces are related to symptom severity in social anxiety disorder. Neuroimage Clin. 2021;30.","DOI":"10.1016\/j.nicl.2021.102615"},{"key":"963_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.neubiorev.2015.02.011","volume":"52","author":"ME Kret","year":"2015","unstructured":"Kret ME, Ploeger A. Emotion processing deficits: a liability spectrum providing insight into comorbidity of mental disorders. Neurosci Biobehav Rev. 2015;52:153\u201371.","journal-title":"Neurosci Biobehav Rev"},{"key":"963_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.tics.2008.09.007","volume":"13","author":"DH Skuse","year":"2009","unstructured":"Skuse DH, Gallagher L. Dopaminergic-neuropeptide interactions in the social brain. Trends Cogn Sci. 2009;13:27\u201335.","journal-title":"Trends Cogn Sci"},{"key":"963_CR50","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.drugalcdep.2018.03.021","volume":"188","author":"MLS Bates","year":"2018","unstructured":"Bates MLS, Hofford RS, Emery MA, Wellman PJ, Eitan S. The role of the vasopressin system and dopamine D1 receptors in the effects of social housing condition on morphine reward. Drug Alcohol Depend. 2018;188:113\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"963_CR51","doi-asserted-by":"crossref","unstructured":"Francis SM, Kim SJ, Kistner-Griffin E, Guter S, Cook EH, Jacob S. ASD and genetic associations with receptors for oxytocin and vasopressin\u2014AVPR1A, AVPR1B, and OXTR. Front Neurosci. 2016;10 NOV:516.","DOI":"10.3389\/fnins.2016.00516"},{"key":"963_CR52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/aur.80","volume":"2","author":"B Chakrabarti","year":"2009","unstructured":"Chakrabarti B, Dudbridge F, Kent L, Wheelwright S, Hill-Cawthorne G, Allison C, et al. Genes related to sex steroids, neural growth, and social-emotional behavior are associated with autistic traits, empathy, and asperger syndrome. Autism Res. 2009;2:157\u201377.","journal-title":"Autism Res"},{"key":"963_CR53","doi-asserted-by":"crossref","unstructured":"Nobile B, Ramoz N, Jaussent I, Dubois J, Guillaume S, Gorwood P et al. Polymorphisms of stress pathway genes and emergence of suicidal ideation at antidepressant treatment onset. Transl Psychiatry. 2020;10.","DOI":"10.1038\/s41398-020-01003-0"},{"key":"963_CR54","doi-asserted-by":"publisher","DOI":"10.3109\/10253890.2010.512376","author":"J Roper","year":"2011","unstructured":"Roper J, O\u2019Carroll AM, Young W, Lolait S. The vasopressin Avpr1b receptor: molecular and Pharmacological studies. Stress. 2011. https:\/\/doi.org\/10.3109\/10253890.2010.512376.","journal-title":"Stress"},{"key":"963_CR55","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1007\/s00726-015-2034-x","volume":"47","author":"J Varga","year":"2015","unstructured":"Varga J, Fodor A, Klausz B, Zelena D. Anxiogenic role of vasopressin during the early postnatal period: maternal separation-induced ultrasound vocalization in vasopressin-deficient Brattleboro rats. Amino Acids. 2015;47:2409\u201318.","journal-title":"Amino Acids"},{"key":"963_CR56","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1210\/en.2006-1309","volume":"148","author":"SJ Lolait","year":"2007","unstructured":"Lolait SJ, Stewart LQ, Jessop DS, Young WS, O\u2019Carroll AM. The hypothalamic-pituitary-adrenal axis response to stress in mice lacking functional vasopressin V1b receptors. Endocrinology. 2007;148:849\u201356.","journal-title":"Endocrinology"},{"key":"963_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00097","author":"A Alacreu-Crespo","year":"2020","unstructured":"Alacreu-Crespo A, Oli\u00e9 E, Guillaume S, Girod C, Cazals A, Chaudieu I, et al. Dexamethasone suppression test May predict more severe\/violent suicidal behavior. Front Psychiatry. 2020. https:\/\/doi.org\/10.3389\/fpsyt.2020.00097.","journal-title":"Front Psychiatry"},{"key":"963_CR58","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.psychres.2006.12.001","volume":"150","author":"J Jokinen","year":"2007","unstructured":"Jokinen J, Carlborg A, M\u00e5rtensson B, Forslund K, Nordstr\u00f6m AL, Nordstr\u00f6m P. DST non-suppression predicts suicide after attempted suicide. Psychiatry Res. 2007;150:297\u2013303.","journal-title":"Psychiatry Res"},{"key":"963_CR59","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jad.2007.06.008","volume":"106","author":"J Jokinen","year":"2008","unstructured":"Jokinen J, Nordstr\u00f6m A-L, Nordstr\u00f6m P. ROC analysis of dexamethasone suppression test threshold in suicide prediction after attempted suicide. J Affect Disord. 2008;106:145\u201352.","journal-title":"J Affect Disord"},{"key":"963_CR60","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/acer.13544","volume":"42","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Rubinstein M, Low MJ, Kreek MJ. V1b receptor antagonist SSR149415 and Naltrexone synergistically decrease excessive alcohol drinking in male and female mice. Alcohol Clin Exp Res. 2018;42:195\u2013205.","journal-title":"Alcohol Clin Exp Res"},{"key":"963_CR61","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/scan\/nsp052","volume":"4","author":"MD Lieberman","year":"2009","unstructured":"Lieberman MD, Cunningham WA. Type I and type II error concerns in fMRI research: Re-balancing the scale. Soc Cogn Affect Neurosci. 2009;4:423\u20138.","journal-title":"Soc Cogn Affect Neurosci"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-025-00963-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12868-025-00963-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-025-00963-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:10:48Z","timestamp":1757250648000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/s12868-025-00963-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["963"],"URL":"https:\/\/doi.org\/10.1186\/s12868-025-00963-7","relation":{},"ISSN":["1471-2202"],"issn-type":[{"type":"electronic","value":"1471-2202"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"17 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The local Ethics Committee (CPP Sud Mediterran\u00e9e IV, CHU Montpellier) approved the study protocol in accordance with the declaration of Helsinki. All participants provided a written informed consent before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}